Skip to main content

International scientific guideline: Reflection paper on non-clinical and clinical development of similar medicinal products containing recombinant interferon alfa

EMEA/CHMP/BMWP/102046/2006 adopted by the Therapeutic Goods Administration (TGA)

Help us improve the Therapeutic Goods Administration site